Biomarkers
/
Heart & Vascular Health
/
Lipoprotein (a)

Lipoprotein (a)

Lipoprotein (a) or Lp(a) is a macromolecular complex composed of one molecule of Low-Density Lipoprotein (LDL) containing apolipoprotein B100 and one molecule of apolipoprotein(a)¹.
Subscribe for updates
By clicking “Subscribe” you agree to our Terms and Privacy Policy.
Your content is on its way!
By clicking “Subscribe” you agree to our TOS and Privacy Policy.
Oops! Something went wrong while submitting the form.
Book your test now
Book a Lipoprotein (a) Test
With Superpower, you have access to a comprehensive range of biomarker tests
Physician reviewed
CLIA-certified labs
HIPAA compliant

Key benefits of Lipoprotein (a) testing

  • Reveals your inherited heart disease risk independent of cholesterol or lifestyle.
  • Flags elevated Lp(a) that silently accelerates plaque buildup in arteries.
  • Explains early heart attacks or strokes despite normal LDL cholesterol levels.
  • Guides aggressive prevention strategies when levels are high (statins, aspirin, lifestyle).
  • Clarifies familial risk so relatives can be screened and protected early.
  • Tracks whether targeted therapies (emerging drugs) may benefit you long-term.
  • Best interpreted once in adulthood; Lp(a) stays stable over time.

What is Lipoprotein (a)?

Lipoprotein (a), often written as Lp(a), is a particle in your blood that carries cholesterol and fats. It's made in the liver and looks similar to LDL cholesterol, but with an extra protein called apolipoprotein (a) attached to its surface. This extra protein makes Lp(a) unique and gives it properties that go beyond simple fat transport.

Your genes decide how much you make

Unlike other cholesterol particles, your Lp(a) level is almost entirely determined by the genes you inherit from your parents. Diet, exercise, and most medications have little effect on it. Once your liver starts producing Lp(a) at a certain level, it tends to stay stable throughout your life.

It may protect wounds but can harm arteries

Scientists believe Lp(a) originally evolved to help with wound healing and tissue repair. But when levels are elevated, Lp(a) can promote inflammation and encourage plaque buildup inside artery walls. This makes it a marker of cardiovascular risk that operates independently of traditional cholesterol measures.

Why is Lipoprotein (a) important?

Lipoprotein (a), or Lp(a), is a cholesterol-carrying particle that behaves more like a genetic fingerprint than a lifestyle marker. Unlike LDL cholesterol, which responds to diet and exercise, Lp(a) levels are largely determined at birth and remain stable throughout life. Elevated Lp(a) promotes inflammation in artery walls and accelerates plaque formation, raising the risk of heart attack and stroke independent of other cardiovascular risk factors.

Your Lp(a) level is written in your DNA

Most people have Lp(a) levels below 30 mg/dL, and lower is better. There is no "low" threshold that causes harm. Values remain consistent from childhood through adulthood, and they don't differ meaningfully between men and women outside of pregnancy, when levels may temporarily rise.

High levels silently accelerate artery damage

When Lp(a) exceeds 50 mg/dL, cardiovascular risk climbs steeply, even in people with otherwise healthy cholesterol profiles. The particle infiltrates artery walls, triggers clotting, and stiffens blood vessels. This process is silent. Most people feel nothing until a cardiac event occurs.

It connects cholesterol, clotting, and inflammation

Lp(a) links lipid metabolism to thrombosis and vascular inflammation, making it a bridge between multiple disease pathways. Elevated levels increase the likelihood of aortic valve stenosis, peripheral artery disease, and recurrent cardiovascular events. Testing once in adulthood reveals inherited risk that standard cholesterol panels miss entirely.

What do my Lipoprotein (a) results mean?

Low lipoprotein (a) levels

Low values usually reflect favorable genetic inheritance. Lipoprotein (a), or Lp(a), is a cholesterol-carrying particle whose blood concentration is largely determined at birth by your genes and remains stable throughout life. Lower levels confer less cardiovascular risk, as Lp(a) promotes both atherosclerosis and clot formation when elevated.

Optimal lipoprotein (a) levels

Being in range suggests your genetically determined Lp(a) level falls within population norms, though optimal truly means lower rather than mid-range. Many labs define normal as below 30 milligrams per deciliter or below 75 nanomoles per liter, but cardiovascular risk begins rising well before these thresholds. The lower your Lp(a), the better for long-term arterial health.

High lipoprotein (a) levels

High values usually reflect inherited genetic variants that increase production of this particle. Elevated Lp(a) independently raises risk for heart attack, stroke, and aortic valve disease by accelerating plaque buildup and enhancing blood clotting. Unlike other lipids, Lp(a) does not respond meaningfully to diet or most standard cholesterol medications.

Factors that influence lipoprotein (a)

Lp(a) levels are remarkably stable across the lifespan and unaffected by fasting, exercise, or typical lifestyle factors. Pregnancy, kidney disease, and thyroid disorders can cause modest changes. Measurement methods vary between labs, so consistency in testing platform matters when tracking over time.

Get precise insights into genetic heart and vascular risk that standard cholesterol tests can miss, with a once-in-a-lifetime measurement that guides lifelong prevention.

Do I need a Lipoprotein (a) test?

Worried about heart disease even though your cholesterol looks normal? Could an invisible genetic risk factor be putting your heart at risk without you knowing?

Lipoprotein (a) is a unique cholesterol particle largely determined by your genes. Elevated levels significantly increase your risk of heart attack and stroke, regardless of your lifestyle.

Testing your Lp(a) gives you a vital snapshot of your inherited cardiovascular risk, empowering you to personalize prevention strategies and protect your heart health proactively. This one-time test could be the missing piece in understanding your true heart disease risk.

Get tested with Superpower

If you’ve been postponing blood testing for years or feel frustrated by doctor appointments and limited lab panels, you are not alone. Standard healthcare is often reactive, focusing on testing only after symptoms appear or leaving patients in the dark.

Superpower flips that approach. We give you full insight into your body with over 100 biomarkers, personalized action plans, long-term tracking, and answers to your questions, so you can stay ahead of any health issues.

With on-demand access to a care team, CLIA-certified labs, and the option for at-home blood draws, Superpower is designed for people who want clarity, convenience, and real accountability - all in one place.

Method: FDA-cleared clinical laboratory assay performed in CLIA-certified, CAP-accredited laboratories. Used to aid clinician-directed evaluation and monitoring. Not a stand-alone diagnosis.

Subscribe for updates
By clicking “Subscribe” you agree to our Terms and Privacy Policy.
Your content is on its way!
By clicking “Subscribe” you agree to our TOS and Privacy Policy.
Oops! Something went wrong while submitting the form.

Similar biomarker tests from Superpower

See more biomarkers

FAQs about Lipoprotein (a)

Lipoprotein (a), or Lp(a), is a cholesterol-carrying particle similar to LDL, but it has an extra protein attached called apolipoprotein(a). This “sticky” protein changes how the particle behaves in the body. Unlike LDL, which often responds to diet and lifestyle, Lp(a) is largely genetic and stays stable over time. Elevated Lp(a) can promote plaque buildup, inflammation, and clotting - raising heart attack and stroke risk even when LDL looks normal.

Lp(a) can reveal inherited cardiovascular risk that standard lipid panels can miss. You can have normal LDL cholesterol and healthy habits yet still have high Lp(a), which independently increases risk for heart attack, stroke, and aortic valve disease. Testing helps explain unexpected or early heart disease in families without traditional risk factors. If Lp(a) is elevated, it can guide more aggressive prevention and influence treatment decisions when routine cholesterol results seem reassuring.

Lp(a) levels are almost entirely set by your DNA early in life and typically remain stable throughout adulthood. That’s why Lp(a) behaves more like a genetic risk factor than a lifestyle-driven biomarker. Diet, exercise, and weight loss generally do not meaningfully lower Lp(a) the way they can affect LDL cholesterol. Because it’s genetically fixed, knowing your Lp(a) level helps you and your clinician focus on controlling modifiable risks like LDL and blood pressure.

Most people have Lp(a) below 30 mg/dL, and lower is better. Values below about 14 mg/dL are often described as optimal and carry minimal added cardiovascular risk. Risk rises progressively, especially above 50 mg/dL, where cardiovascular risk can climb steeply - sometimes compared to familial hypercholesterolemia. Very high levels (for example, above 100 mg/dL) raise greater concern. Lab thresholds can vary, so interpret results with the reporting reference range.

High Lp(a) can still drive atherosclerosis and increase heart attack and stroke risk even when LDL is normal. Lp(a) can deposit cholesterol in artery walls and may increase inflammation and clotting, creating “hidden risk” not captured by standard cholesterol testing. An elevated result may signal the need for earlier, more aggressive prevention - often focusing on lowering LDL further and optimizing blood pressure and other risk factors to offset the inherited Lp(a)-related risk.

Lp(a) is linked to cardiovascular disease through multiple mechanisms. It can infiltrate artery walls and contribute to plaque formation, while also promoting inflammation. It may interfere with normal clot breakdown, increasing the tendency toward thrombosis. This combination can accelerate atherosclerosis and raise the risk of heart attack and stroke. High Lp(a) is also associated with aortic valve disease (including aortic valve stenosis), sometimes appearing earlier in life without obvious warning symptoms.

Because Lp(a) levels are genetically determined and tend to remain stable over time, testing once in adulthood is usually sufficient. A one-time result can act as a lifelong cardiovascular risk marker. Repeat testing may be considered if there are factors that can modestly alter results or complicate interpretation (such as certain illnesses or lab differences). In most people, however, Lp(a) doesn’t fluctuate like other lipids, so frequent rechecks typically aren’t necessary.

Lp(a) is generally stable, but acute illness, kidney disease, and estrogen therapy can modestly affect levels. Another common issue is lab-to-lab variation: assay methods differ, so results are not always directly comparable across laboratories. That means a small change between tests may reflect method differences rather than a true biological shift. For the clearest interpretation, it’s helpful to consider the lab’s reference range and, when possible, use the same lab method for comparisons.

The main value of finding high Lp(a) is that it can influence treatment intensity, especially when standard lipid numbers appear normal. Elevated Lp(a) may guide decisions about statins and PCSK9 inhibitors as part of an aggressive prevention strategy - particularly focusing on lowering LDL cholesterol and overall risk. While Lp(a) itself often doesn’t respond strongly to typical lifestyle changes, identifying high Lp(a) helps justify earlier or more intensive therapy to counterbalance inherited cardiovascular risk.

Low or normal Lp(a) is generally protective and does not cause symptoms or known health problems. There is no established benefit to having higher Lp(a); lower is consistently considered better for cardiovascular risk. A low result simply reflects a favorable genetic profile for this specific risk factor. Even with low Lp(a), overall cardiovascular risk still depends on other factors (like LDL cholesterol and blood pressure), but Lp(a) itself is not a concern when naturally low.